Abstract
Systemic administrations (0.1, 0.5, and 2 mg/kg) of α1-adrenoreceptor (AR) antagonist prazosin dose-dependently attenuated cold allodynia in a rat tail model of neuropathic pain, whereas α2-AR antagonist yohimbine exacerbated it. These results suggest that the functions of α1- and α2-AR in this model are excitatory and inhibitory, respectively, consistent with their general properties. It is also proposed that cold allodynia can be reversed by α1-AR antagonist and exacerbated by α2-AR antagonist.
Original language | English |
---|---|
Pages (from-to) | 207-210 |
Number of pages | 4 |
Journal | Brain Research |
Volume | 1039 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - 2005 Mar 28 |
Bibliographical note
Funding Information:This work was supported by a grant from Ministry of Health and Welfare, Republic of Korea (HMP-00-CO-01-0001).
Keywords
- Cold allodynia
- Neuropathic pain
- Prazosin
- Yohimbine
- α1-adrenoreceptor
- α2-adrenoreceptor
ASJC Scopus subject areas
- Neuroscience(all)
- Molecular Biology
- Clinical Neurology
- Developmental Biology